Site icon pharmaceutical daily

Ablynx in warrant exercise

Ablynx

Ablynx

Belgian company Ablynx said Monday that it has issued an additional 19.833 common shares, in exchange for €121.444.

As a result of this transaction, Ablynx now has 61.153.032 shares outstanding.

The total number of rights to subscribe to not yet issued securities conferring voting rights currently is 2.860.214 which equals the total number of voting rights that may result from the exercise of these warrants.

Currently 1.000 convertible bonds are outstanding entitling the holders thereof to 7.733.952 shares of Ablynx in the aggregate, upon conversion of such convertible bonds, the company said.

Exit mobile version